Literature DB >> 16531539

CARD15 allele frequency differences in New Zealand Maori: ancestry specific susceptibility to Crohn's disease in New Zealand?

R B Gearry, R A Lea, R L Roberts, G K Chambers, M L Barclay, M A Kennedy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16531539      PMCID： PMC1856176          DOI： 10.1136/gut.2005.085464

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  10 in total

1.  A study of ulcerative colitis in New Zealand, showing a low incidence in Maoris.

Authors:  R D WIGLEY; B P MACLAURIN
Journal:  Br Med J       Date:  1962-07-28

Review 2.  Prospects for admixture mapping of complex traits.

Authors:  Paul M McKeigue
Journal:  Am J Hum Genet       Date:  2004-11-11       Impact factor: 11.025

3.  Gene-environment interaction modulated by allelic heterogeneity in inflammatory diseases.

Authors:  Mathias Chamaillard; Dana Philpott; Stephen E Girardin; Habib Zouali; Suzanne Lesage; Fabrice Chareyre; The Hung Bui; Marco Giovannini; Ulrich Zaehringer; Virginie Penard-Lacronique; Philippe J Sansonetti; Jean-Pierre Hugot; Gilles Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-07       Impact factor: 11.205

4.  Rapid detection of common CARD15 variants in patients with inflammatory bowel disease.

Authors:  Rebecca L Roberts; Richard B Gearry; Murray L Barclay; Martin A Kennedy
Journal:  Mol Diagn       Date:  2004

5.  Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease.

Authors:  J P Hugot; M Chamaillard; H Zouali; S Lesage; J P Cézard; J Belaiche; S Almer; C Tysk; C A O'Morain; M Gassull; V Binder; Y Finkel; A Cortot; R Modigliani; P Laurent-Puig; C Gower-Rousseau; J Macry; J F Colombel; M Sahbatou; G Thomas
Journal:  Nature       Date:  2001-05-31       Impact factor: 49.962

6.  A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease.

Authors:  Y Ogura; D K Bonen; N Inohara; D L Nicolae; F F Chen; R Ramos; H Britton; T Moran; R Karaliuskas; R H Duerr; J P Achkar; S R Brant; T M Bayless; B S Kirschner; S B Hanauer; G Nuñez; J H Cho
Journal:  Nature       Date:  2001-05-31       Impact factor: 49.962

7.  Differential effects of NOD2 variants on Crohn's disease risk and phenotype in diverse populations: a metaanalysis.

Authors:  Michael Economou; Thomas A Trikalinos; Konstantinos T Loizou; Epameinondas V Tsianos; John P A Ioannidis
Journal:  Am J Gastroenterol       Date:  2004-12       Impact factor: 10.864

8.  Inflammatory bowel disease in Auckland, New Zealand.

Authors:  R J Eason; S P Lee; C Tasman-Jones
Journal:  Aust N Z J Med       Date:  1982-04

9.  Crohn's disease: a ten year retrospective review at Dunedin hospitals.

Authors:  M Schlup; B P Maclaurin; G O Barbezat; B M de Lambert
Journal:  N Z Med J       Date:  1986-03-12

10.  The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease.

Authors:  Andrew P Cuthbert; Sheila A Fisher; Muddassar M Mirza; Kathy King; Jochen Hampe; Peter J P Croucher; Silvia Mascheretti; Jeremy Sanderson; Alastair Forbes; John Mansfield; Stefan Schreiber; Cathryn M Lewis; Christopher G Mathew
Journal:  Gastroenterology       Date:  2002-04       Impact factor: 22.682
  10 in total
  3 in total

Review 1.  Inflammatory bowel disease in australasian children and adolescents.

Authors:  A S Day; D A Lemberg; R B Gearry
Journal:  Gastroenterol Res Pract       Date:  2014-03-30       Impact factor: 2.260

2.  Latitude, sunshine, and human lactase phenotype distributions may contribute to geographic patterns of modern disease: the inflammatory bowel disease model.

Authors:  Andrew Szilagyi; Henry Leighton; Barry Burstein; Xiaoqing Xue
Journal:  Clin Epidemiol       Date:  2014-05-27       Impact factor: 4.790

Review 3.  Systematic review and meta-analysis of lactose digestion, its impact on intolerance and nutritional effects of dairy food restriction in inflammatory bowel diseases.

Authors:  Andrew Szilagyi; Polymnia Galiatsatos; Xiaoqing Xue
Journal:  Nutr J       Date:  2016-07-13       Impact factor: 3.271
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.